51
|
Schytte T, Nielsen T, Moeller D, Hoffmann L, Khalil A, Knap M, Lund M, Nyhus C, Hansen T, Ottosson W, Borissova S, Appelt A, Brimk C, Hansen O. PO-0754: Safe inhomogeneus RT dose escalation in locally advanced NSCLC, -interim results from NARLAL2. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31064-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
52
|
Hoffmann L, Bertholet J, Nordsmark M, Kruhlikava I, Helbo B, Schmidt M, Poulsen P. PO-0934: Detailed mapping of time-resolved 3D intra- and inter-fractional oesophageal tumour motion. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31244-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
53
|
Moeller D, Nordsmark M, Nyeng T, Alber M, Hoffmann L. PO-0958: Anatomical changes in oesophageal cancer patients: Posterior beam IMPT is more robust than IMRT. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31268-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
54
|
Mlinarić M, Hoffmann L, Kunst AE, Richter M. Tabakkontrollpolitiken auf lokaler Ebene in Deutschland und Irland – Ein qualitativer Most-Different-Vergleich aus dem SILNE-R-Projekt. DAS GESUNDHEITSWESEN 2017. [DOI: 10.1055/s-0037-1605982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
55
|
Schröder SL, Fink A, Hoffmann L, Schumann N, Martin O, Richter M. Sozioökonomische Unterschiede in den Wegen zur Diagnostik der koronaren Herzkrankheit – einequalitative Studie aus Patientensicht. DAS GESUNDHEITSWESEN 2017. [DOI: 10.1055/s-0037-1605663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
56
|
Hoffmann L, Schumann N, Richter M. Methamphetaminkonsum in Mitteldeutschland: Eine qualitative Studie zu Konsumentengruppen und -motiven aus Expertensicht. DAS GESUNDHEITSWESEN 2017. [DOI: 10.1055/s-0037-1605619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
57
|
Hoffmann L, Schumann N, Richter M. Zugang zur stationären Rehabilitation bei Methamphetaminabhängigkeit – Barrieren und Optimierungspotenziale aus Expertenperspektive. DAS GESUNDHEITSWESEN 2017. [DOI: 10.1055/s-0037-1605687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
58
|
Lutz C, Møller D, Hoffmann L, Khalil A, Knap M, Alber M. EP-1614: Uncertainty of dose-volume constraints obtained from radiation pneumonitis dose-response analysis. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32049-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
59
|
Hoffmann L, Khalil A, Knap M, Alber M, Møller D. OC-0487: Pre-treatment characteristics can predict anatomical changes occurring during RT in lung cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30927-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
60
|
Hoffmann L, Alber M, Jensen M, Holt M, Møller D. PO-0876: Treatment adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31313-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
61
|
Hansen O, Knap M, Khalil A, Nyhus C, Brink C, Hoffmann L, Schytte T. EP-1229: Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC). Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31664-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
62
|
Haraldsen A, Lutz C, Hoffmann L, Khalil A, Møller D. OC-0068: Heterogeneous dose escalation in lung: How robust are high FDG-uptake volumes during radiotherapy? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30512-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
63
|
Nyeng T, Nordsmark M, Hoffmann L. EP-1661: Adaptive strategy to accommodate anatomical changes during RT in oesophageal cancer patients. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32193-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
64
|
Møller D, Alber M, Nyeng T, Nordsmark M, Hoffmann L. PO-0877: Proton therapy of oesophageal cancer is more robust against anatomical changes than photons. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31314-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
65
|
Lutz CM, Møller DS, Hoffmann L, Knap MM, Alber M. Reliability of dose volume constraint inference from clinical data. Phys Med Biol 2017; 62:3250-3262. [PMID: 28350545 DOI: 10.1088/1361-6560/aa63d4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Dose volume histogram points (DVHPs) frequently serve as dose constraints in radiotherapy treatment planning. An experiment was designed to investigate the reliability of DVHP inference from clinical data for multiple cohort sizes and complication incidence rates. The experimental background was radiation pneumonitis in non-small cell lung cancer and the DVHP inference method was based on logistic regression. From 102 NSCLC real-life dose distributions and a postulated DVHP model, an 'ideal' cohort was generated where the most predictive model was equal to the postulated model. A bootstrap and a Cohort Replication Monte Carlo (CoRepMC) approach were applied to create 1000 equally sized populations each. The cohorts were then analyzed to establish inference frequency distributions. This was applied to nine scenarios for cohort sizes of 102 (1), 500 (2) to 2000 (3) patients (by sampling with replacement) and three postulated DVHP models. The Bootstrap was repeated for a 'non-ideal' cohort, where the most predictive model did not coincide with the postulated model. The Bootstrap produced chaotic results for all models of cohort size 1 for both the ideal and non-ideal cohorts. For cohort size 2 and 3, the distributions for all populations were more concentrated around the postulated DVHP. For the CoRepMC, the inference frequency increased with cohort size and incidence rate. Correct inference rates >[Formula: see text] were only achieved by cohorts with more than 500 patients. Both Bootstrap and CoRepMC indicate that inference of the correct or approximate DVHP for typical cohort sizes is highly uncertain. CoRepMC results were less spurious than Bootstrap results, demonstrating the large influence that randomness in dose-response has on the statistical analysis.
Collapse
|
66
|
Hoffmann L, Böhme K. Wird sprachlicher Förderbedarf in der Grundschule sicher erkannt? Zur Klassifikationsgüte von diagnostischen Entscheidungen. ZEITSCHRIFT FUR PADAGOGISCHE PSYCHOLOGIE 2017. [DOI: 10.1024/1010-0652/a000203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Zusammenfassung. Additive Sprachfördermaßnahmen basieren auf einer vorgelagerten Entscheidung, ob bei einem Kind ein sprachlicher Förderbedarf besteht. Im vorliegenden Beitrag, in dem die Sprachförderdiagnostik in Grundschulen anhand von Daten der IQB-Ländervergleichsstudie 2011 betrachtet wird, gehen wir der Frage nach, welche diagnostische Güte solche Entscheidungen aufweisen. Darüber hinaus wird untersucht, inwieweit die Entscheidungsgüte mit der Nutzung bestimmter diagnostischer Informationsquellen (u.a. Beobachtungen durch Lehrkräfte, Schulnoten, sprachdiagnostische Verfahren) kovariiert. Unsere Ergebnisse zeigen, dass in den Schulen nur ein geringer Anteil der Kinder mit sprachlichem Förderbedarf korrekt identifiziert wird (geringe Sensitivität). Hingegen werden Kinder ohne Förderbedarf zumeist zuverlässig erkannt (hohe Spezifität). Positive Zusammenhänge mit der Diagnosegüte wurden lediglich für den Einsatz sprachdiagnostischer Verfahren (z.B. Tests) gefunden, wobei eine maßgebliche Verbesserung der Diagnosegüte offenbar nur dann erzielt wird, wenn sprachliche Kompetenzen nicht nur einmalig, sondern mehrfach erfasst werden.
Collapse
|
67
|
Brinkmann KO, Zhao J, Pourdavoud N, Becker T, Hu T, Olthof S, Meerholz K, Hoffmann L, Gahlmann T, Heiderhoff R, Oszajca MF, Luechinger NA, Rogalla D, Chen Y, Cheng B, Riedl T. Suppressed decomposition of organometal halide perovskites by impermeable electron-extraction layers in inverted solar cells. Nat Commun 2017; 8:13938. [PMID: 28067308 PMCID: PMC5336555 DOI: 10.1038/ncomms13938] [Citation(s) in RCA: 215] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2016] [Accepted: 11/15/2016] [Indexed: 12/25/2022] Open
Abstract
The area of thin-film photovoltaics has been overwhelmed by organometal halide perovskites. Unfortunately, serious stability concerns arise with perovskite solar cells. For example, methyl-ammonium lead iodide is known to decompose in the presence of water and, more severely, even under inert conditions at elevated temperatures. Here, we demonstrate inverted perovskite solar cells, in which the decomposition of the perovskite is significantly mitigated even at elevated temperatures. Specifically, we introduce a bilayered electron-extraction interlayer consisting of aluminium-doped zinc oxide and tin oxide. We evidence tin oxide grown by atomic layer deposition does form an outstandingly dense gas permeation barrier that effectively hinders the ingress of moisture towards the perovskite and—more importantly—it prevents the egress of decomposition products of the perovskite. Thereby, the overall decomposition of the perovskite is significantly suppressed, leading to an outstanding device stability. The stability issue of perovskite-based solar cells is in part due to electrode corrosion. Here, Brinkmann et al. develop an impermeable bilayered electron-extraction layer between the active layer and the electrode, suppressing decomposition of the perovskite and preventing corrosion from the inside.
Collapse
|
68
|
Molitor D, Behr M, Hoffmann L, Evers D. Research Note: Benefits and Drawbacks of Pre-bloom Applications of Gibberellic Acid (GA3) for Stem Elongation in Sauvignon blanc. S AFR J ENOL VITIC 2016. [DOI: 10.21548/33-2-1119] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
69
|
Pasquali M, Serchi T, Cocco E, Leclercq CC, Planchon S, Guignard C, Renaut J, Hoffmann L. Corrigendum to: A Fusarium graminearum strain-comparative proteomic approach identifies regulatory changes triggered by agmatine [J. Proteomics (2016) 137; 107-116]. J Proteomics 2016; 140:111. [PMID: 27140391 DOI: 10.1016/j.jprot.2016.04.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
70
|
Hoffmann L, Knap M, Khalil A, Møller D. OC-0363: Dose escalation in lung cancer patients, the dosimetric implications of inter-fractional change. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31612-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
71
|
Moeller D, Holt M, Alber M, Knap M, Khalil A, Hoffmann L. OC-0364: Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31613-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
72
|
Moeller D, Hoffmann L, Lutz C, Nielsen T, Brink C, Appelt A, Lund M, Nielsen M, Ottosson W, Khalil A, Knap M, Hansen O, Schytte T. OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31794-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
73
|
Kandi M, Hoffmann L, Fledelius J, Farr K, Moeller D, Knap M, Khalil A. EP-1223: Local failure after radical radiotherapy of NSCLC in relation to the pre-therapeutic PET/CT. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32473-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
74
|
Nielsen T, Brink C, Moeller D, Hoffmann L, Lutz C, Appelt A, Lund M, Nielsen M, Ottosson W, Khalil A, Knap M, Hansen O, Schytte T. EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33183-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
75
|
Schmidt M, Hoffmann L, Knap M, Rasmussen T, Folkersen B, Toftegaard J, Møller D, Poulsen P. OC-0215: Mapping of breathing and cardiac induced motion of lymph node targets in lung cancer patients. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31464-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|